Blog - Page 3 of 5667 - QualityStocks

MondayJun 22, 2026 11:15 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets a $393 Billion Heart Disease Problem with Epigenetics and AI

For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in 2020 to $1.4 trillion by 2050, almost quadrupling in size. What makes Cardio Diagnostics' approach distinct, and what gives the company a defensible clinical position, is its ability to detect coronary heart disease earlier and with high sensitivity. The company's recent commercial and regulatory milestones give additional shape to the investment thesis. Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According…

MondayJun 22, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Expands Patent Portfolio Targeting Future Commercial Texatron(TM) Fusion Engine(TM) Platform

American Fusion has filed a new patent application covering innovations expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform. Management believes the technologies disclosed in the filing could ultimately support hundreds of additional patent applications as the platform evolves, with a growing intellectual property portfolio focused on fusion energy generation, plasma control, system architecture, and energy-delivery technologies. Through its wholly owned subsidiary, Kepler Fusion Technologies, American Fusion(TM) is pursuing a modular approach to fusion energy deployment, targeting industrial and commercial customers through behind-the-meter energy deployments before broader grid-scale applications. The company is currently developing multiple…

MondayJun 22, 2026 10:30 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), was featured in a BioMedWire editorial highlighting its development of Lucid-MS, a patented, first-in-class drug candidate designed to directly protect the myelin sheath damaged by multiple sclerosis. Unlike conventional MS treatments that primarily target the immune system, Lucid-MS is being developed as a non-immunomodulatory neuroprotective therapy and is preparing to enter Phase 2 clinical trials following successful Phase 1 safety and tolerability studies. The editorial notes that Lucid-MS has demonstrated the ability to prevent and reverse myelin degradation in preclinical…

MondayJun 22, 2026 10:20 am

QualityStocksNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Signs Drilling Contract for 2026 Skaergaard Field Program

Greenland Mines (NASDAQ: GRML) announced it has awarded a diamond drilling contract to Nordisk Fundering A/S for the 2026 field campaign at its 80%-owned Skaergaard precious and critical metals project in southeast Greenland. The planned program will include approximately 7,500 meters of helicopter-supported diamond core drilling aimed at advancing resource categories, collecting additional metallurgical material and supporting geotechnical studies for potential future open-pit development scenarios. Greenland Mines said the integrated campaign will utilize three helicopter-portable drill rigs and will generate geological, metallurgical and engineering data to support mine planning and broader development studies. The company noted that Nordisk Fundering's Arctic…

MondayJun 22, 2026 9:50 am

QualityStocksNewsBreaks – What Are I Bonds and Why Are They Paying 4.26%?

CNW PocketChange Exploring the concepts, products and innovations influencing currencies, digital assets and global finance. Series I Savings Bonds currently offer a composite interest rate of 4.26% for bonds issued between May 1 and Oct. 31, 2026. I Bonds are backed by the U.S. government and designed to help protect investors from inflation. Investors can redeem I Bonds after one year, although bonds cashed before five years forfeit the last three months of interest. June 22, 2026 – via CurrencyNewsWire -- Series I Savings Bonds, commonly known as I Bonds, are U.S. government-backed savings bonds designed to help preserve purchasing power…

MondayJun 22, 2026 9:50 am

QualityStocksNewsBreaks – Nocera, Inc. (NASDAQ: NCRA) Highlights CampaignPulse.ai Investment and Expands AI Platform Vision

Nocera (NASDAQ: NCRA) provided additional details regarding its minority equity investment in CampaignPulse.ai, an artificial intelligence-driven platform being developed to help organizations simulate audience responses, test messaging strategies and evaluate campaign effectiveness before committing resources to real-world deployment. The platform is expected to leverage large language models, predictive analytics and simulation-based modeling to support applications across political campaigns, corporate communications, public affairs, fundraising, investor relations, marketing and reputation management. Nocera said CampaignPulse.ai is expected to complement its broader artificial intelligence strategy alongside its pending venture platform agreement with Digital Innovations Group, which is expected to provide access to the IRMA…

MondayJun 22, 2026 9:45 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Closes in on Initial Production as Gold Prices Hold High

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Near-term gold producer LaFleur Minerals is preparing to restart production at its Beacon Gold Mill located in the Abitibi Gold Belt, using a 100,000-metric tonne bulk sample from its nearby Swanson Gold Project as a feed source for its first gold pour The company expects to benefit from market prices in the $4,400 to $4,500 range to generate healthy revenue above its $2,750-an-ounce base case with an all-in sustaining cost of just under $1,600 an ounce LaFleur’s strategic acquisition of mining projects, development of…

MondayJun 22, 2026 9:40 am

QualityStocksNewsBreaks – Foreign Investors Added $206 Billion to U.S. Securities in April, Treasury Reports

CNW CurrenSees Exploring the policies, markets and global events influencing currencies and the movement of money worldwide Foreign investors purchased a net $206.0 billion of long-term U.S. securities in April. Overall net foreign purchases of long-term securities totaled an estimated $103.1 billion. Total Treasury International Capital (TIC) inflows reached $26.1 billion despite a decline in foreign holdings of Treasury bills. June 22, 2026 – via CurrencyNewsWire -- According to newly released Treasury International Capital (TIC) data from the U.S. Department of the Treasury, foreign investors increased their holdings of long-term U.S. securities in April, recording net purchases of $206.0 billion.…

MondayJun 22, 2026 9:30 am

QualityStocksNewsBreaks – M-tron Industries, Inc. (NYSE American: MPTI) Secures $6.8 Million Follow-On Defense Order for C-UAS Radar Programs

M-tron Industries (NYSE American: MPTI) announced a $6.8 million follow-on order from a U.S. Department of Defense contractor supporting multiple counter-unmanned aircraft system ("C-UAS") radar programs. The order includes several products, including high-performance oven-controlled crystal oscillators, with work scheduled to be performed in Orlando, Florida, through 2027. The company said the radar program is gaining traction across U.S. defense procurement channels and federal civilian agencies and is expected to remain in production beyond 2030. Mtron noted the award reflects continued demand for its precision RF components used in defense and aerospace applications, including radar, electronic warfare, communications, drones, autonomous vehicles,…

MondayJun 22, 2026 9:20 am

QualityStocksNewsBreaks – Knight Therapeutics Inc. (TSX: GUD) Repays Credit Facility Used to Fund Paladin Acquisition

This article has been disseminated on behalf of Knight Therapeutics Inc. and may include paid advertising. Knight Therapeutics (TSX: GUD) announced that it has repaid all outstanding amounts under its revolving credit facility with National Bank of Canada and a syndicate of lenders. The company had drawn $60 million from the facility in June 2025 to help finance its acquisition of Paladin. Knight said the repayment was funded through strong cash flow generated by its operations in Canada and Latin America. The revolving credit facility continues to provide borrowing capacity of up to US$100 million, with an additional US$100 million…

Site Search

Company Search